ESC 365 - Possibility of the CAVI as the risk factor of development of heart failure with preserved left ventricular ejection fraction

HFA Premium Access

Possibility of the CAVI as the risk factor of development of heart failure with preserved left ventricular ejection fraction

Session: Poster session 3 - HFpEF - Heart failure with preserved ejection fraction

Topic: HFpEF - Heart failure with preserved ejection fraction

Speaker: Doctor K. Takagi (Chapel Hill, US)

Event: Heart Failure 2017 - 4th World Congress on Acute Heart Failure

Congress Presentation

Add to my library

About the speaker

Doctor Koji Takagi

Momentum Research, Inc., Chapel Hill (United States of America)

0 follower

16 more presentations in this session

Effect of drug treatment on quality of life in heart failure with preserved ejection fraction: a systematic review and meta-analysis of randomised controlled trials

Speaker: Doctor S. Zheng (London, GB)

Prognostic impact of blood pressure values in patients with heart failure with preserved ejection fraction

Speaker: Doctor M. Goncalves (Viseu, PT)

Exercise training in diastolic heart failure (Ex-DHF): rationale and design of a multicentre, prospective, randomized, controlled, parallel group trial

Speaker: Doctor A. Feuerstein (Berlin, DE)

Left atrial volume index predicts major adverse cardiovascular events in patients with ischemic chronic heart failure with preserved ejection fraction and renal dysfunction

Speaker: Professor D. Lashkul (Zaporizhzhya, UA)

The comorbidity in patients with heart failure and preserved ejection fraction depending on age

Access the full session

Poster session 3 - HFpEF - Heart failure with preserved ejection fraction

Speakers: Doctor K. Takagi, Doctor S. Zheng, Doctor M. Goncalves, Doctor A. Feuerstein, Professor D. Lashkul

About the event

Heart Failure 2017 - 4th World Congress on Acute Heart Failure

29 April - 2 May 2017

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources